Verici Dx plc (AIM:VRCI)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.2000
-0.0050 (-2.44%)
Nov 6, 2026, 4:23 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 7.94 million as of November 6, 2026. It is the 40,825th most valuable company in the world and the 909th biggest in the United Kingdom. Its market cap has decreased by 16.05% in one year.
Market Cap
7.94M
Enterprise Value
6.71M
Revenue
2.65M
Global Rank
Country Rank
#909 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 7.94M, a decrease of -84.65%. That is a compound annual growth rate of -26.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 7.94M | -27.63% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.79B |
| GSK plc | 75.77B |
| Haleon | 30.01B |
| Smith & Nephew | 9.90B |
| Thalia Therapeutics | 10.21M |
| Aptamer Group | 9.85M |
| Fusion Antibodies | 7.20M |
| CRISM Therapeutics | 6.93M |